Liminatus Pharma Inc. (LIMN) at a glance

Liminatus Pharma Inc. (LIMN) is a micro-cap Healthcare company. It trades at $0.1, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 52/100 overall. Its strongest dimension is Safety (90/100) and its weakest is Momentum (12/100). It is a relatively defensive holding with below-market volatility.

Price

$0.10

Market cap

$5.5M

P/E ratio

n/a

Dividend yield

None

Beta

0.70

52-week range

$0.10 to $33.66